Showing results (3061-3070 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 13, 2013
A rational approach to identify inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductaseMahesh T Chhabria, Kailash B Parmar, Pathik S BrahmkshatriyaCurrent Pharmaceutical Design|February 12, 2013
The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cellsMaria Grazia Cipolleschi, Elisabetta Rovida, Persio Dello SbarbaCurrent Pharmaceutical Design|February 12, 2013
Non invasive indexes for the assessment of patients with non-alcoholic fatty liver diseaseSalvatore Petta, Aase Handberg, Antonio CraxìCurrent Pharmaceutical Design|February 12, 2013
Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectorsNatalia V Petukhova, Tatiana V Gasanova, Liudmila A Stepanova, et al.Current Pharmaceutical Design|February 12, 2013
Veterinary vaccines from transgenic plants: highlights of two decades of research and a promising exampleHoang Trong Phan, Doreen M Floss, Udo ConradCurrent Pharmaceutical Design|November 28, 2012
From bortezomib to other inhibitors of the proteasome and beyondDaniela Buac, Min Shen, Sara Schmitt, et al.Current Pharmaceutical Design|June 13, 2013
Stable gastric pentadecapeptide BPC 157-NO-system relationPredrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.Current Pharmaceutical Design|April 10, 2013
Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseasesAltan Onat, Günay CanCurrent Pharmaceutical Design|April 10, 2013
Platelets in rheumatic diseases: friend or foe?Armen Yuri Gasparyan, Lilit Ayvazyan, Etheresia Pretorius, et al.Current Pharmaceutical Design|April 10, 2013
Targeting platelet-neutrophil interactions in giant-cell arteritisMattia Baldini, Angelo A Manfredi, Norma MaugeriPageof 1,008